OCI — Orecap Invest Income Statement
0.000.00%
- CA$18.58m
- CA$2.59m
- 56
- 44
- 66
- 56
Annual income statement for Orecap Invest, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | C2022 October 31st | R2023 October 31st | 2024 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.147 | -0.224 | 0.497 | 2.76 | 1.05 |
Operating Profit | -0.147 | 0.224 | -0.497 | -2.76 | -1.05 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.147 | 0.224 | -2 | -2.78 | 10.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.14 | 0.593 | -2 | -2.4 | 10.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.14 | 0.593 | -2 | -4.75 | 9.65 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.14 | 0.593 | -2 | -4.75 | 9.65 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.001 | 0.001 | -0.008 | 0.002 | 0.044 |